heart attack Tagged Articles
Bayer shells out millions to settle more Yaz lawsuits
Bayer, maker of the blockbuster birth control pills Yaz and Yasmin, will pay at least $120 million to settle about 500 lawsuits claiming that the pills caused dangerous and sometimes deadly blood clots. The settlement is the first wave of
Obesity, diabetes during pregnancy linked to autism, developmental delays
Mothers who are obese or have diabetes during pregnancy are more likely to have children who are autistic than women who do not have the same conditions while pregnant, according to a new study from the University of California.
Weighing the side effects of Pradaxa vs. Warfarin
Pradaxa, the first in a new generation of blood thinners, hit the market in October 2010 with much promise and fanfare. The medication, designed to prevent strokes in patients with a particular type of irregular heartbeat, was the first alternative
Pradaxa patients exposed to higher cardiac risks, uncontrollable bleeding
Boehringer Ingelheim’s anti-clotting drug Pradaxa has been widely hailed in the medical community as a long-anticipated alternative to the 54-year-old drug warfarin, but recent studies confirm the newcomer drug may put patients at higher risk of heart attack and other
Serious bleeding events associated with blood thinner Pradaxa
Just a year after the Food and Drug Administration (FDA) approved Pradaxa (dabigatran) to prevent blood clots in patients with a life threatening type of irregular heartbeat known as atrial fibrillation, the agency announced it was looking into reports of
FDA rejects Merck’s new combo cholesterol drug
Merck & Co. will have to provide more data on its experimental cholesterol-lowering drug cocktail before the Food and Drug Administration (FDA) will allow it to be sold in the United States. The drug, known only as MK-0653C, is designed
FDA panel recommends approval of controversial diet drug Qnexa
A new diet drug may soon be available for people battling the bulge, but it may come at a price. This week, a Food and Drug Administration (FDA) advisory panel reviewed clinical data on the weight loss drug Qnexa and
FDA considers approval of diet drug despite birth defects, heart risks
Drug maker Vivus Inc., is hoping to win Food and Drug Administration (FDA) approval for its diet drug Qnexa this week after a rejection in 2010 due to serious health concerns. Experts say the chances of the weight loss drug
Watchdog group pushes FDA panel to revote on Yaz safety
A consumer watchdog group is calling for a revote by a Food and Drug Administration (FDA) advisory panel, after discovering that some members of the panel had ties to drug companies that made the pills under review.
